News Articles Tagged: HDAC Inhibitor
Vorinostat: A Targeted Anti-Tumor Drug Powder Explained
Understand the targeted anti-tumor action of Vorinostat powder. Learn about its role as an HDAC inhibitor and its significance in modern cancer treatment strategies.
High-Purity Vorinostat Powder (CAS 149647-78-9) for Cancer Research
Access high-purity Vorinostat powder (99%+) for your cancer research. Learn about its HDAC inhibitor properties and importance as a targeted anti-tumor drug. Buy from China.
Unlocking the Power of Butyrate: A Deep Dive into its Anticancer Mechanisms
Explore how Sodium Butyrate, a metabolite of dietary fiber, acts as a potent anticancer agent by modulating cellular metabolism, inhibiting SIRT3, and inducing apoptosis.
Sourcing High-Quality Sodium Phenylbutyrate for Your Research and Synthesis Needs
Learn where to source high-quality Sodium Phenylbutyrate (4-PBA, CAS 1716-12-7) for chemical synthesis and research, including its applications as a pharmaceutical intermediate and HDAC inhibitor, from NINGBO INNO PHARMCHEM CO.,LTD.
The Importance of 4-PBA in Advancing Therapeutic Research
Learn about the critical role of 4-PBA (Sodium Phenylbutyrate, CAS 1716-12-7) in therapeutic research, particularly as an HDAC inhibitor and its potential in treating various diseases, from NINGBO INNO PHARMCHEM CO.,LTD.
The Science Behind Sodium Phenylbutyrate: A Deep Dive into its Properties and Uses
Delve into the chemical and biological properties of Sodium Phenylbutyrate (CAS 1716-12-7), also known as 4-PBA. Understand its applications as a synthesis material and its significance as an HDAC inhibitor in research, by NINGBO INNO PHARMCHEM CO.,LTD.
Sodium Phenylbutyrate: Applications as a Pharmaceutical Raw Intermediate
Learn about Sodium Phenylbutyrate (CAS 1716-12-7), its significance as a pharmaceutical raw intermediate, and its potential therapeutic applications as an HDAC inhibitor. Supplied by NINGBO INNO PHARMCHEM CO.,LTD.
The Role of 4-PBA in Chemical Synthesis and Biomedical Research
Explore the applications of 4-PBA (Sodium Phenylbutyrate, CAS 1716-12-7) as a synthesis material and its impact on biomedical research, including its use as an HDAC inhibitor, presented by NINGBO INNO PHARMCHEM CO.,LTD.
Understanding Sodium Phenylbutyrate: A Key Intermediate in Pharmaceutical Development
Discover the role of Sodium Phenylbutyrate (4-PBA) as a vital pharmaceutical intermediate. Learn about its properties, applications in synthesis, and potential in therapeutic research, from NINGBO INNO PHARMCHEM CO.,LTD.
Butyric Acid in Pharmaceuticals: A Histone Deacetylase Inhibitor with Therapeutic Promise
Explore the pharmaceutical applications of butyric acid as a histone deacetylase inhibitor, its role in cancer therapy, and its potential for treating various diseases. Insights from NINGBO INNO PHARMCHEM CO.,LTD.
Spotlight on 3-Hydroxybutyric Acid: A Key Player in Metabolic Health and Cellular Signaling
Delve into the dual role of 3-Hydroxybutyric Acid as a crucial energy substrate during ketosis and a signaling molecule influencing cellular epigenetics and health outcomes.
The Pharmaceutical Potential of 3-Hydroxybutyric Acid: Beyond Basic Metabolism
Explore the therapeutic avenues of 3-Hydroxybutyric Acid, focusing on its HDAC inhibitory properties and potential applications in neurological and metabolic disorders.
3-Hydroxybutyric Acid: A Hidden Gem for Cognitive Health and Brain Function
Explore the neuroprotective and cognitive-enhancing properties of 3-Hydroxybutyric Acid, its function as an HDAC inhibitor, and its potential in supporting brain health.
Unlocking the Power of 3-Hydroxybutyric Acid: Your Guide to Ketosis and Energy
Explore the science behind 3-Hydroxybutyric Acid, its role in ketogenic diets, and how it fuels your body and brain for optimal performance. Learn about the benefits of beta-hydroxybutyrate.
Tributyrin in Pharmaceuticals: A Prodrug with Therapeutic Potential
Explore the pharmaceutical applications of Tributyrin, focusing on its prodrug capabilities, histone deacetylase inhibitory activity, and its potential in cancer treatment and drug delivery.
Ethyl Isonipecotate: Advancing Treatment for Inflammatory Diseases
Learn about the promising role of Ethyl Isonipecotate (CAS: 1126-09-6) as an HDAC inhibitor for inflammatory diseases. NINGBO INNO PHARMCHEM CO.,LTD. supplies high-purity Ethyl Isonipecotate for research and development.
Sodium Butyrate as an HDAC Inhibitor: Implications for Cancer Therapy
Discover how Sodium Butyrate's ability to inhibit Histone Deacetylase (HDAC) opens doors for novel cancer therapies and epigenetic modulation.
Vorinostat: A Comprehensive Overview of its Chemical Properties and Clinical Impact
This article provides a detailed look at Vorinostat, its chemical structure, its function as an HDAC inhibitor, its approved use in CTCL, and its potential in new therapeutic areas.
Vorinostat: Unlocking Therapeutic Potential Through Epigenetic Modulation
A comprehensive overview of Vorinostat, detailing its function as an HDAC inhibitor, its clinical applications in CTCL, and emerging research areas like HIV and other diseases.
Vorinostat: A Deep Dive into HDAC Inhibition and Therapeutic Applications
An in-depth exploration of Vorinostat, focusing on its HDAC inhibitory properties, its role in cancer treatment, and the ongoing research expanding its therapeutic scope.
Vorinostat: A Key Pharmaceutical Intermediate in Cancer Treatment and Beyond
Explore the comprehensive profile of Vorinostat, from its detailed chemical properties and applications to its market availability and the importance of reliable sourcing.
The Science Behind Vorinostat: Mechanism, Applications, and Future Prospects
Delve into the scientific intricacies of Vorinostat, from its HDAC inhibition mechanism to its diverse applications in oncology and beyond, highlighting key research findings.
Exploring the Therapeutic Potential of Vorinostat: An HDAC Inhibitor's Journey
Discover the multifaceted applications and scientific advancements surrounding Vorinostat, a key HDAC inhibitor, and understand its impact on cancer treatment and beyond.